David Holland
David is a Partner in Carpmaels’ Life Sciences group. He has been leading the firm’s UPC preparations since the early excitement about the new patent system back in 2014. His practice focuses on managing interrelated oppositions and appeals at the EPO, with a particular focus on platform protection and freedom to operate. David regularly supports pan-European litigation with the Carpmaels’ Dispute Resolution team, so he has seen the pros and cons of the current patchwork of national courts first hand. He expects the UPC to provide a valuable forum for disputes as the new system comes to life. David is often asked to share his UPC expertise, both through industry-wide events and also as a guest lecturer at the Industrial Property Course held by the Politecnico di Milano which entitles European patent attorneys to act before the UPC.
Natalia Wegner
Natalia specialises in complex biotechnological subject matter, in particular cell and gene therapies, nucleic acid technologies, antibody-based drugs and engineered therapeutic proteins. She handles mainly European prosecution and opposition cases that require a coordinated strategic approach and often involve multiple parties and associated ongoing or looming disputes. Natalia has particular experience obtaining and defending key patents in relation to commercially valuable products and technologies, as well as advising on and attacking competitors’ IP. A large part of Natalia’s work also involves advising on SPCs, and she has been closely involved in high profile SPC litigation nationally and at the CJEU.
Xuefang Wu
Yiorgos Christakis
Vinod Das
Tina Morrison
Subha Madhavan
Peter Mesenbrink
Murthy Devarakonda
